Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 3 IN DEXTROSE 10 AND SODIUM CHLORIDE 0 2 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 3 IN DEXTROSE 10 AND SODIUM CHLORIDE 0 2 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Potassium chloride replenishes intracellular potassium; dextrose provides caloric energy; sodium chloride maintains extracellular fluid osmolality. The combination corrects fluid, electrolyte, and caloric deficits.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
Intravenous infusion: 0.3% KCl, 10% dextrose, 0.2% NaCl solution administered at 100-125 mL/hour (providing 3-3.75 mEq KCl/hour). Typical adult dose: 10-20 mEq KCl per hour via continuous infusion, not to exceed 20 mEq/hour or 200 mEq/day. Rate adjusted based on serum potassium and clinical response.
None Documented
None Documented
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Potassium: rapid redistribution half-life ~0.5-1 hour; terminal elimination half-life ~2-4 hours, dependent on renal function and total body potassium stores. Dextrose: negligible (rapidly metabolized; half-life <15 minutes). Sodium: 2-4 hours under normal regulation. Clinical context: half-lives are dose-independent and reflect body's homeostatic control.
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Potassium: renal (90% excreted unchanged, primarily via distal tubule and collecting duct secretion; minor fecal loss ~10%). Dextrose: metabolized to CO2 and water (renal excretion of glucose negligible unless hyperglycemia exceeds renal threshold). Sodium: renal (95% excreted unchanged, regulated by aldosterone). Chloride: renal (primarily reabsorbed; excreted as counterion for ammonium or potassium).
Category C
Category A/B
Electrolyte
Electrolyte